Genome-wide copy-number profiling revealed the gains and losses typical of ACC (Fig. 3) [15-17], fitting a rare BCOR/HDAC9-mutant subset of the recognized spectrum. This evidence concerns the gene HDAC9 and adrenal cortex carcinoma.